Christa Buechler

University Hospital Regensburg

Germany

Research Interests

Explore related searches

Professors in Germany

Contact this professor

ORCID

Google Scholar

Articles (31)

Decline in Serum Lysophosphatidylcholine Species in Patients with Severe Inflammatory Bowel Disease

Article Link

Year:

2025

Fecal Arachidonic Acid: A Potential Biomarker for Inflammatory Bowel Disease Severity

Article Link

Year:

2025

Cholesteryl Ester Species but Not Serum Proprotein Convertase Subtilisin/Kexin Type 9 Levels Decline in Male Patients with Active Inflammatory Bowel Disease

Article Link

Year:

2025

Galectin-3—Insights from Inflammatory Bowel Disease and Primary Sclerosing Cholangitis

Article Link

Year:

2025

Distinct Plasma LPC Signatures Differentiate COVID-19 Sepsis from Other Sepsis Aetiologies

Article Link

Year:

2025

Editorial for the Special Issue: Recent Advances in Adipokines—2nd Edition

Article Link

Year:

2025

Editorial for the Special Issue: Feature Reviews in Adipokines

Article Link

Year:

2025

The Niemann–Pick C1 Protein of Patients with Hepatocellular Carcinoma Is Associated with Survival Time in Males and Tumor Size in Females

Article Link

Year:

2025

Lower Plasma IL-32 Levels Linked to Better Survival in Sepsis

Article Link

Year:

2025

Elevated Serum Presepsin Identifies Herpes Simplex Virus-1 Reactivation in COVID-19 Patients

Article Link

Year:

2025

Rising Lysophosphatidylcholine Levels Post-Hepatitis C Clearance

Article Link

Year:

2024

Chemerin Levels in COVID-19 Are More Affected by Underlying Diseases than by the Virus Infection Itself

Article Link

Year:

2024

Calprotectin, a Promising Serological Biomarker for the Early Diagnosis of Superinfections with Multidrug-Resistant Bacteria in Patients with COVID-19

Article Link

Year:

2024

Hepatic Amyloid Beta-42-Metabolizing Proteins in Liver Steatosis and Metabolic Dysfunction-Associated Steatohepatitis

Article Link

Year:

2024

Lipid Metabolism Disorders as Diagnostic Biosignatures in Sepsis

Article Link

Year:

2024

High Serum S100A12 as a Diagnostic and Prognostic Biomarker for Severity, Multidrug-Resistant Bacteria Superinfection and Herpes Simplex Virus Reactivation in COVID-19

Article Link

Year:

2024

Proprotein Convertase Subtilisin/Kexin Type 9 Induction in COVID-19 Is Poorly Associated with Disease Severity and Cholesterol Levels

Article Link

Year:

2024

Reduced Plasma Bone Morphogenetic Protein 6 Levels in Sepsis and Septic Shock Patients

Article Link

Year:

2024

Serum Phosphatidylcholine Species 32:0 as a Biomarker for Liver Cirrhosis Pre- and Post-Hepatitis C Virus Clearance

Article Link

Year:

2024

Urinary Hydroxyproline as an Inflammation-Independent Biomarker of Inflammatory Bowel Disease

Article Link

Year:

2024

Serum Adiponectin Predicts COVID-19 Severity

Article Link

Year:

2024

Saturated Fat-Mediated Upregulation of IL-32 and CCL20 in Hepatocytes Contributes to Higher Expression of These Fibrosis-Driving Molecules in MASLD

Article Link

Year:

2023

Chemerin and Chemokine-like Receptor 1 Expression in Ovarian Cancer Associates with Proteins Involved in Estrogen Signaling

Article Link

Year:

2023

Chemerin and Chemokine-like Receptor 1 Expression Are Associated with Hepatocellular Carcinoma Progression in European Patients

Article Link

Year:

2023

Plasma Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) as a Possible Biomarker for Severe COVID-19

Article Link

Year:

2023

Plasma Chemerin Is Induced in Critically Ill Patients with Gram-Positive Infections

Article Link

Year:

2023

Gender-Specific Differences in Serum Sphingomyelin Species in Patients with Hepatitis C Virus Infection—Sphingomyelin Species Are Related to the Model of End-Stage Liver Disease (MELD) Score in Male Patients

Article Link

Year:

2023

Fecal and Urinary Adipokines as Disease Biomarkers

Article Link

Year:

2023

Expression and Function of BMP and Activin Membrane-Bound Inhibitor (BAMBI) in Chronic Liver Diseases and Hepatocellular Carcinoma

Article Link

Year:

2023

HCV Infection and Liver Cirrhosis Are Associated with a Less-Favorable Serum Cholesteryl Ester Profile Which Improves through the Successful Treatment of HCV

Article Link

Year:

2022

Loss of Chemerin in Rhabdomyosarcoma Cells Polarizes Adjacent Monocytes to an Immunosuppressive Phenotype

Article Link

Year:

2022

Collaborators (7)

Herbert Schwarz

National University of Singapore

SINGAPORE

Thomas Weiss

Faculty, Professor (Associate)

University Hospital Regensburg

GERMANY

Oliver Treeck

Professor (Associate) Dr. rer. nat. (PhD), Research Group Leader "Molecular Gynecologic Oncology"

GERMANY

Gerhard Liebisch

University of Regensburg

GERMANY

Marcus Höring

University Hospital Regensburg

GERMANY

Florian Weber

University of Regensburg

GERMANY

Thomas Grewal

Associate Professor

University of Sydney

AUSTRALIA

Christa Buechler

Research Interests

Explore related searches

Contact this professor

Articles (31)

Decline in Serum Lysophosphatidylcholine Species in Patients with Severe Inflammatory Bowel Disease

Fecal Arachidonic Acid: A Potential Biomarker for Inflammatory Bowel Disease Severity

Cholesteryl Ester Species but Not Serum Proprotein Convertase Subtilisin/Kexin Type 9 Levels Decline in Male Patients with Active Inflammatory Bowel Disease

Galectin-3—Insights from Inflammatory Bowel Disease and Primary Sclerosing Cholangitis

Distinct Plasma LPC Signatures Differentiate COVID-19 Sepsis from Other Sepsis Aetiologies

Editorial for the Special Issue: Recent Advances in Adipokines—2nd Edition

Editorial for the Special Issue: Feature Reviews in Adipokines

The Niemann–Pick C1 Protein of Patients with Hepatocellular Carcinoma Is Associated with Survival Time in Males and Tumor Size in Females

Lower Plasma IL-32 Levels Linked to Better Survival in Sepsis

Elevated Serum Presepsin Identifies Herpes Simplex Virus-1 Reactivation in COVID-19 Patients

Rising Lysophosphatidylcholine Levels Post-Hepatitis C Clearance

Chemerin Levels in COVID-19 Are More Affected by Underlying Diseases than by the Virus Infection Itself

Calprotectin, a Promising Serological Biomarker for the Early Diagnosis of Superinfections with Multidrug-Resistant Bacteria in Patients with COVID-19

Hepatic Amyloid Beta-42-Metabolizing Proteins in Liver Steatosis and Metabolic Dysfunction-Associated Steatohepatitis

Lipid Metabolism Disorders as Diagnostic Biosignatures in Sepsis

High Serum S100A12 as a Diagnostic and Prognostic Biomarker for Severity, Multidrug-Resistant Bacteria Superinfection and Herpes Simplex Virus Reactivation in COVID-19

Proprotein Convertase Subtilisin/Kexin Type 9 Induction in COVID-19 Is Poorly Associated with Disease Severity and Cholesterol Levels

Reduced Plasma Bone Morphogenetic Protein 6 Levels in Sepsis and Septic Shock Patients

Serum Phosphatidylcholine Species 32:0 as a Biomarker for Liver Cirrhosis Pre- and Post-Hepatitis C Virus Clearance

Urinary Hydroxyproline as an Inflammation-Independent Biomarker of Inflammatory Bowel Disease

Serum Adiponectin Predicts COVID-19 Severity

Saturated Fat-Mediated Upregulation of IL-32 and CCL20 in Hepatocytes Contributes to Higher Expression of These Fibrosis-Driving Molecules in MASLD

Chemerin and Chemokine-like Receptor 1 Expression in Ovarian Cancer Associates with Proteins Involved in Estrogen Signaling

Chemerin and Chemokine-like Receptor 1 Expression Are Associated with Hepatocellular Carcinoma Progression in European Patients

Plasma Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) as a Possible Biomarker for Severe COVID-19

Plasma Chemerin Is Induced in Critically Ill Patients with Gram-Positive Infections

Gender-Specific Differences in Serum Sphingomyelin Species in Patients with Hepatitis C Virus Infection—Sphingomyelin Species Are Related to the Model of End-Stage Liver Disease (MELD) Score in Male Patients

Fecal and Urinary Adipokines as Disease Biomarkers

Expression and Function of BMP and Activin Membrane-Bound Inhibitor (BAMBI) in Chronic Liver Diseases and Hepatocellular Carcinoma

HCV Infection and Liver Cirrhosis Are Associated with a Less-Favorable Serum Cholesteryl Ester Profile Which Improves through the Successful Treatment of HCV

Loss of Chemerin in Rhabdomyosarcoma Cells Polarizes Adjacent Monocytes to an Immunosuppressive Phenotype

Collaborators (7)

Herbert Schwarz

Thomas Weiss

Oliver Treeck

Gerhard Liebisch

Marcus Höring

Florian Weber

Thomas Grewal

How do I reach out?

Meet Kite AI